Estimation of invasive pneumococcal disease dynamics parameters and the impact of conjugate vaccination in Australia

Mathematical Biosciences and Engineering

Volumn 5, Issue 1, 2008, Pages 175-204

  Sutton, Karyn L ^a   Banks, H T ^b   Castillo CHáVEZ, Carlos ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Inverse problems; Pneumococcal infection dynamics; Population model; Statistical methods

Indexed keywords

STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 45849153889     PISSN: 15471063     EISSN: 15510018     Source Type: Journal    
DOI: 10.3934/mbe.2008.5.175     Document Type: Article

References (40)

1. A. S. Artz, W. B. Ershler, and D. L. Longo. Pneumococcal vaccination and revaccination of older adults, Clinical Microbiology Reviews 16 (2003), 308-318.
2. Australian Bureau of Statistics, 33010 Births, Australia, 2005. http://www.abs.gov.au/AUSSTATS/abs@.nsf/ProductsbyCatalogue/FF9E15176D6887D8C A2568A9001393B2?OpenDocument.
3. Australian Bureau of Statistics, 33020 Deaths, Australia, 2005. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/C67A858BA00CB846CA2568A9001393 C6.
4. Australian Bureau of Statistics, Australian Demographic Statistics: Table 4. Estimated Resident Population, States and Territories (Number). http://www.abs.gov.au/ausstats/abs@.nsf/0e5fa1cc95cd093c4a2568110007852b/ 6949409dc8b 8fb92ca256bc60001b3dl!OpenDocument.
5. Australian Government: Department of Health and Ageing, Health and Ageing Factbook 2006. Chapter 1; Section: Ageing Population. http://www.health.gov.au/ internet/wcms/ publishing.nsf/content/factbook2006-1∼factbook2006-ch1- introduction∼chapter1-sect-3.
6. Australian Government: Department of Health and Ageing, Health and Ageing Factbook 2006. Chapter 6; Section: Age Profile. http://www.health.gov.au/ internet/wcms/ publishing.nsf/Content/Factbook2006-1∼factbook2006-ch6- introduction∼chapter6-sect-2.
7. H. T. Banks, M. Davidian, and J.R. Samuels, Jr. An inverse problem statistical methodology summary, Center for Research in Scientific Computation Technical Report, CRSC-TR07-14, August, 2007, North Carolina State University.
8. A. E. Bridy-Pappas, M. B. Margolis, K. J. Center, and Isaacman. Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention, Pharmacotherapy 25 (2005), 1193-1212.
9. R. Cohen, C. Levy, F. de La Rocque, N. Gelbert, A. Wollner, B. Fritzeil, E. Bonnet, R. Tetelboum, and E. Varon. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media, Pediatric Infectious Diseases Journal 25 (2006), 1001-1007.
10. Communicable Diseases Australia, National Notifiable Diseases Surveillance System. http://www9.health.gov.au/cda/Source/CDA-index.cfm.
11. M. Davidian and D. M. Giltinan, "Nonlinear Models for Repeated Measurement Data," Chapman and Hall/CRC, Boca Raton, Florida, 1995.
12. S. F. Dowell, C. G. Whitney, C. Wright, C. E. Rose Jr., A. Schuchat. Seasonal patterns of invasive pneumococcal disease, Emerging Infectious Diseases 9 (2003), 573-579.
13. A. R. Gallant, "Nonlinear Statistical Models. Wiley Series in Probability and Mathematical Statistics: Applied Probability and Statistics, " John Wiley &: Sons, Inc., New York, New York, 1987.
14. F. Ghaffar, T. Barton, J. Lozano, L. S. Muniz, P. Hicks, V. Gan, N. Ahmad, and G. H. McCracken Jr. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life, Clinical Infectious Diseases 39 (2004), 930-938.
15. M. A. Gordon, A. L. Walsh, M. Chaponda, D. Soko, M. Mbvwinji, M. E. Molyneux, and S. B. Gordon. Bacteraemia and mortality among adult medical admissions in Malawi - predominance, of non-typhi Salmonellae and Streptococcus pneumoniae, Journal of Infection 42 (2001), 44-49.
16. D. Hansman, S. Morris, M. Gregory, and B. McDonald, B. Pneumococcal carriage amongst Australian aborigines in Alice Springs, Northern Territory, Journal of Hygiene 95 (1985), 677-684.
17. D. Hansman and S. Morris. Pneumococcal carriage amongst children in Adelaide, South Australia Epidemiology and Infection 101 (1988), 411-417.
18. J. O. Hendley, Frederick G. Hayden, and Birgit Winther, Weekly point prevalence of Streptococcus pneumoniae, Hemophilus influenzae and Moraxella catarrhalis in the upper airways of normal young children: effect of respiratory illness and season, acta pathologica, microbiologica, et immunologica Scandinavica 113 (2005), 213-220.
19. M. Hussain, A. Melegaro, R. G. Pebody, R. George, W. J. Edmunds, R. Talukdar, S. A. Martin, A. Efstratiou, and E. Miller. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting, Epidemiology and Infection 133 (2005), 891-898.
20. R. I. Jennrich, Asymptotic properties of non-linear least squares estimators, Ann Math Statist 40 (1969), 633-643.
21. P. Kalima, F. X. Emmanuel, and T. Riordan. Epidemiology of Streptococcus pneumoniae infections at the Edinburgh City Hospital: 1980-95, Epidemiology and Infection 122 (1999), 251-257.
22. P. Marchisio, S. Gironi, S. Esposito, G. C. Schito, S. Mannelli, N. Principi, and Ascanius Project Collaborative Group. Seasonal variations in nasopharyngeal carriage of respiratory pathogens in healthy Italian children attending day-care centres or schools, Journal of Medical Microbiology 50 (2001), 1095-1099.
23. E. V. Millar, K. L. O'Brien, J. P. Watt, M. A. Bronsdon, J. Dallas, C. G. Whitney, R. Reid, and M. Santosham. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population, Clinical Infectious Diseases 43 (2006), 8-15.
24. M. R. Moore, T. B. Hyde, T. W. Hennessy, D. J. Parks, A. L. Reasonover, M. Harker-Jones, J. Gove, D. L. Bruden, K. Rudolph, A. Parkinson, J. C. Butler, and A. Schuchat. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska, Journal of Infectious Diseases 190 (2004), 2031-2038.
25. D. M. Musher, Streptococcus pneumoniae, in "Mandell, Douglas, and Bennett's principles and practice of infectious diseases" (eds. G. E. Mandell, J. E. Bennett and R. Dolin), Churchill Livingstone, (2000), 2128-2144.
26. M. J. Owen, C. D. Baldwin, P. R. Swank, A. K. Pannu, D. L. Johnson, and V. M. Howie. Relation of infant feeding practices, cigarette smoking exposure, and group child care to the onset and duration of otitis media with effusion in the first two years of life, Journal of Pediatrics 123 (1993), 702-711.
27. J. L. Paradise, H. E. Rockette, D. K. Colborn, B. S. Bernard, C. G. Smith, M. Kurs-Laskey, and J. E. Janosky. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life, Pediatrics 99 (1997), 318-333.
28. S. I. Pelton, A. M. Loughlin, and C. D. Marchant. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities, Pediatric Infectious Disease Journal 23 (2004), 1015-1022.
29. G. Peter and J. O. Klein. Streptococcus pnuemoniae. in "Principles and Practice of Pediatric Infectious Diseases" (eds. S. S. Long, L. K. Pickering and C. G. Prober), Churchill Livingstone (2002), 739-746.
30. K. A. Robinson, W. Baughman, G. Rothrock, N. L. Barrett, M. Pass, C. Lexau, B. Damaske, K. Stefonek, B. Barnes, J. Patterson, E. R. Zell, A. Schuchat, and C. G. Whitney. Epidemiolgy of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era, Journal of American Medical Association 285 (2001), 1729-1735.
31. P. Roche, V. Krause, R. Andrews, L. Carter, D. Coleman, H. Cook, M. Counahan, C. Giele, R. Gilmore, S. Hart, and R. Pugh. Invasive pneumococcal disease in Australia, 2002, Communicable Diseases Intelligence 27 (2003), 466-477.
32. P. Roche, V. Krause, M. Bartlett, D. Coleman, H. Cook, M. Counahan, C. Davis, L. Del Fabbro, C. Geile, R. Gilmore, R. Kampen, and M. Young. Invasive pneumococcal disease in Australia, 2003, Communicable Diseases Intelligence 28 (2004), 441-454.
33. P. W. Roche, V. L. Krause, M. Bartlett, D. Coleman, H. Cook, C. Davis, J. E. Fielding, R. Holland, C. Giele, R. Gilmour, and R. Kampen. Invasive pneumococcal disease in Australia, 2004, Communicable Diseases Intelligence 30 (2006), 80-92.
34. P. Roche, V. Krause, and H. Cook. Invasive pneumococcal disease in Australia, 2005, Communicable Diseases Intelligence 31 (2007), 86-100.
35. G. A. F. Seber and C. J. Wild, "Nonlinear Regression, " John Wiley & Sons, Inc., New York, New York, 1989.
36. E. Stubbs, K. Hare, C. Wilson, P. Morris, and A. J. Leach. Streptococcus pneumoniae and noncapsular Haemophilus influenzae nasal carriage and hand contamination in children: a comparison of two populations at risk of otitis media Pediatric Infectious Disease Journal 24 (2005), 423-428.
37. T. R. Talbot, K. A. Poehling, T. V. Hartert, P. G. Arbogast, N. B. Halasa, K. M. Edwards, W. Schaffner, A. S. Craig, and M. R. Griffin. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation, American Journal of Medicine 118 (2005), 285-291.
38. M. Watson, K. Bayley, J. M. Bell, G. W. Gilbert, G. Hogg, A. D. Keil, V. Krause, D. Murphy, P. Roche, H. V. Smith, M. G. Stewart, J. Stylianopoulos, and J. Turnidge. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002-implications for vaccine serotype coverage, Communicable Diseases Intelligence 27 (2003), 478-487.
39. K. Watson, K. Carville, J. Bowman, P. Jacoby, T. V. Riley, A. J. Leach, and D. Lehmann. Upper respiratory tract bacterial carriage in aboriginal and non-aboriginal children in a semi-arid area of western Australia, Pediatric Infectious Disease Journal 25 (2006), 782-790.
40. World Health Organization, Pneumococcal vaccines, WHO Weekly Epidemiological Record 79 (1999), 177-183.